Dr. Bajwa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-1721Fax+1 617-726-6878
Education & Training
- Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
- New York University School of MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2002 - 2025
Clinical Trials
- LIPS-A: Lung Injury Prevention Study With Aspirin Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 1 citationsPhase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Di...Ednan K Bajwa, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina
International Journal of Chronic Obstructive Pulmonary Disease. 2024-01-01 - 8 citationsEffects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH).Ednan K Bajwa, Dawn Cislak, John Palcza, Hwa-Ping Feng, Eric J Messina
Respiratory Medicine. 2023-01-01 - 1 citationsMedication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.Tracey J Weiss, Dena Rosen Ramey, Lingfeng Yang, Xinyue Liu, Mahesh J Patel
BMC Pulmonary Medicine. 2022-10-18
Grant Support
- Molecular Markers Of Risk, Phenotype, And Outcomes In ARDSNational Heart, Lung, And Blood Institute2008–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: